A novel drug, evenamide, quieted overactive brain circuits in an animal model of schizophrenia, improving memory, social ...

Recent studies have examined the relationship between the drug and psychoses and looked at how the brain responds to the ...

New preclinical research in Neuropsychopharmacology focuses on the unique mechanism and site of action of evenamide as a ...

A new animal study has found that prenatal exposure to bisphenol A — a chemical commonly found in plastics — can lead to ...

Some individuals with schizophrenia who were treated with antibody suppressant drugs to treat biological disorders saw their ...

The authors of an opinion piece in The Lancet Psychiatry make a case for paying more attention to the autistic features of ...

A University of Wyoming researcher led a study that used mice to show that social hierarchy involves status-dependent ...

Mice treated with MK-801—an inhibitor of NMDA receptors—exhibit a range of schizophrenia-like behaviors, including hyperactivity, social deficits, and cognitive impairment.

Impairment in glutamate-mediated neurotransmission has been implicated in schizophrenia. Further, blockade of N-methyl-D-aspartate (NMDA) receptors induces schizophrenia-like behaviors in humans.

Impairment in glutamate-mediated neurotransmission has been implicated in schizophrenia. Further, blockade of N-methyl-D-aspartate (NMDA) receptors induces schizophrenia-like behaviors in humans.